1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlersMcVernon, J.; Nolan, T.; Richmond, P.; Reynolds, G.; Nissen, M.; Lambert, S.; Marshall, H.; Papa, T.; Rehm, C.
2018The impact of the 13 valent conjugate pneumococcal vaccine on pneumococcal serotypes causing childhood empyema in AustraliaStrachan, R.; Beggs, S.; Fearon, D.; Gilbert, G.; Homaira, N.; Lambert, S.; Marshall, H.; Martin, A.; McCallum, G.; McCullagh, A.; McDonald, T.; Mcintyre, P.; Oftadeh, S.; Ranganathan, S.; Suresh, S.; Teoh, L.; Twaij, A.; Wainwright, C.; Wong, M.; Snelling, T.; et al.; The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting 2018 (23 Mar 2018 - 27 Mar 2018 : Adelaide, AUSTRALIA)
2010Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trialNolan, T.; McVernon, J.; Skeljo, M.; Richmond, P.; Wadia, U.; Lambert, S.; Nissen, M.; Marshall, H.; Booy, R.; Heron, L.; Hartel, G.; Lai, M.; Basser, R.; Gittleson, C.; Greenberg, M.
2013Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescentsLambert, S.; Chuk, L.; Nissen, M.; Nolan, T.; McVernon, J.; Booy, R.; Heron, L.; Richmond, P.; Walls, T.; Marshall, H.; Reynolds, G.; Hartel, G.; Hu, W.; Lai, M.
2015Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in AustraliaMarshall, H.; Richmond, P.; Nissen, M.; Lambert, S.; Booy, R.; Reynolds, G.; Sebastian, S.; Pride, M.; Jansen, K.; Anderson, A.; Scully, I.
2011Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of ageBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Heron, L.; Lambert, S.; Caubet, M.; Mesaros, N.; Boutriau, D.
2013Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlersBooy, R.; Richmond, P.; Nolan, T.; McVernon, J.; Marshall, H.; Nissen, M.; Reynolds, G.; Ziegler, J.; Stoney, T.; Heron, L.; Lambert, S.; Mesaros, N.; Peddiraju, K.; Miller, J.
2012A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trialRichmond, P.; Nissen, M.; Marshall, H.; Lambert, S.; Roberton, D.; Gruber, W.; Jones, T.; Arora, A.
2012Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsBryant, K.; McVernon, J.; Marchant, C.; Nolan, T.; Marshall, G.; Richmond, P.; Marshall, H.; Nissen, M.; Lambert, S.; Aris, E.; Mesaros, N.; Miller, J.

Discover